White matter hyperintensities and their role in major depressive episodes: a cross-sectional study in adults under 65

Edouard Baudouin1, Emmanuelle Corruble2, Pietro Gori3

  • 1MOODS Team, L'Institut National de la Santéet de la Recherche Medicale, Centre de Recherche en Epidémiologie et Santédes Populations, Facultéde Médecine Paris-Saclay, Université Paris-Saclay, Le Kremlin Bicêtre, France. Department of Geriatrics, Assistance Publique-Hôpitaux de Paris, Hôpitaux Universitaires Paris-Saclay, Hôpital Paul-Brousse, Villejuif, France.

Revista Brasileira De Psiquiatria (Sao Paulo, Brazil : 1999)
|December 28, 2024
PubMed
Abstract

Insights

In adults under 65, white matter hyperintensities (WMH) volume did not differ between Major Depressive Episodes (MDE) patients and controls. However, WMH volume mediated the effect of age on MDE severity.

Area of Science:

  • Neuroimaging
  • Psychiatry
  • Gerontology

Background:

  • White matter hyperintensities (WMH) are linked to Major Depressive Episodes (MDE) in older adults.
  • The association between WMH volume and MDE in adults under 65 is not well understood.

Purpose of the Study:

  • To investigate the relationship between WMH volume and MDE, and its severity, in individuals under 65.
  • To explore WMH as a potential mediator in the age-MDE severity relationship.

Main Methods:

  • Cross-sectional study of 69 MDE patients and 32 healthy controls (<65 years).
  • WMH volume quantified by expert raters.
  • MDE severity assessed using the Hamilton Rating Scale.
  • Mediation analyses performed.

Main Results:

  • No significant difference in WMH volume between MDE patients and controls.
  • Significantly higher WMH volume observed in extremely severe MDE cases.
  • WMH volume fully mediated the effect of age on MDE severity.

Conclusions:

  • WMH volume is not a distinguishing factor for MDE in adults under 65 compared to controls.
  • WMH may play a mediating role in how age influences MDE severity.
  • Findings suggest WMH could contribute to depression severity in later life.

Related Concept Videos

Depressive Disorders: MDD and Dysthymia01:27

Depressive Disorders: MDD and Dysthymia

Depressive disorders are a group of mental health conditions characterized by pervasive feelings of sadness, diminished pleasure in life, and a significant impact on daily functioning. These conditions are most prevalent in individuals during their 30s and affect women at twice the rate of men. Contrary to popular belief, younger individuals are generally more susceptible to these disorders than older adults. Two key types of depressive disorders include Major Depressive Disorder (MDD) and...
16
Depression: Overview01:18

Depression: Overview

Depression is a prevalent mental illness marked by persistent sadness and lack of interest in previously enjoyable activities. It can take several forms, including major depression, persistent depressive disorder, and bipolar I and II disorders. Symptoms range from emotional changes like chronic worry to physical changes like sleep disturbances and suicidal thoughts. From a neurobiological perspective, depression is believed to be triggered by abnormalities in the brain's prefrontal cortex,...
186
Depressive Disorders: Etiology01:27

Depressive Disorders: Etiology

Depressive disorders result from a complex interplay of biological, psychological, and sociocultural factors, each contributing uniquely to the development and persistence of the condition. Understanding these factors provides critical insight into the multifaceted nature of depression.
Biological Factors in Depression
Biological predispositions significantly influence the risk of developing depressive disorders. Genetic studies highlight the role of variations in the serotonin transporter...
17
Antidepressant Drugs: MAOIs and Other Agents01:23

Antidepressant Drugs: MAOIs and Other Agents

Atypical antidepressants, including bupropion (Wellbutrin), mirtazapine (Remeron), nefazodone (Serzone), trazodone (Desyrel), and vilazodone (Viibryd), offer unique mechanisms of action. Bupropion weakly inhibits dopamine and norepinephrine reuptake, aiding depression treatment and smoking cessation, with a low risk of sexual dysfunction. Mirtazapine enhances serotonin and norepinephrine neurotransmission, leading to sedation, increased appetite, and weight gain. As a result, it helps treat...
157
Long-term Depression01:03

Long-term Depression

Long-term depression, or LTD, is one of the ways by which synaptic plasticity—changes in the strength of chemical synapses—can occur in the brain. LTD is the process of synaptic weakening that occurs over time between pre and postsynaptic neuronal connections. The synaptic weakening of LTD works in opposition to synaptic strengthening by long-term potentiation (LTP) and together are the main mechanisms that underlie learning and memory.
Calcium Ion Concentration Mechanism
If over...
2.4K
Attention-Deficit/Hyperactivity Disorder01:30

Attention-Deficit/Hyperactivity Disorder

Attention-deficit/hyperactivity disorder (ADHD) is a neurodevelopmental disorder characterized by persistent inattention, hyperactivity, and impulsivity. It affects approximately 5-8% of children globally, with around 60-70% of cases persisting into adulthood. ADHD has significant implications for educational attainment, social interactions, and occupational success.
Diagnostic Criteria and Symptoms
To diagnose ADHD, symptoms must manifest before age 12 and be evident across multiple settings....
21